Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

507 ARTÍCULOS , VIENDO DEL 151 AL 165

Classification of the primary progressive aphasias: principles and review of progress since 2011

Vandenberghe R.

Alzheimers Res Ther. 2016 Apr 21;8(1):16. doi: 10.1186/s13195-016-0185-y.

Interventions Targeting Reversible Dementia in Down Syndrome

Callahan BL, Wong C, Ngang PN, Wolf U, Freedman M.

J Am Geriatr Soc. 2016 Apr;64(4):917-9. doi: 10.1111/jgs.14068.

Delirium in the geriatric unit: proton-pump inhibitors and other risk factors

Otremba I, Wilczyński K, Szewieczek J.

Clin Interv Aging. 2016 Apr 4;11:397-405. doi: 10.2147/CIA.S103349. eCollection 2016.

Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study

Müller M, Kuiperij HB, Versleijen AA, Chiasserini D, Farotti L, Baschieri F, Parnetti L, Struyfs H, De Roeck N, Luyckx J, Engelborghs S, Claassen JA, Verbeek MM.

J Alzheimers Dis. 2016 Apr 16;52(4):1321-33. doi: 10.3233/JAD-160038.

Diagnostic Distortions: A Case Report of Progressive Apraxia of Speech

Brodtmann A, Pemberton H, Darby D, Vogel AP.

J Alzheimers Dis. 2016 Apr 19;53(1):79-83. doi: 10.3233/JAD-160069.

Nutrition and risk of dementia: overview and methodological issues

Morris MC.

Ann N Y Acad Sci. 2016 Mar;1367(1):31-7. doi: 10.1111/nyas.13047.

Effects of moderate beer consumption on health and disease: A consensus document

de Gaetano G, Costanzo S, Di Castelnuovo A, Badimon L, Bejko D, Alkerwi A, Chiva-Blanch G, Estruch R, La Vecchia C, Panico S, Pounis G, Sofi F, Stranges S, Trevisan M, Ursini F, Cerletti C, Donati MB, Iacoviello L.

Nutr Metab Cardiovasc Dis. 2016 Jun;26(6):443-67. doi: 10.1016/j.numecd.2016.03.007. Epub 2016 Mar 31.

Disentangling the Treatment of Agitation in Alzheimer's Disease

Howard RJ.

Am J Psychiatry. 2016 May 1;173(5):441-3. doi: 10.1176/appi.ajp.2016.16010083.

The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia

Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, Lopez OL, Mahoney J, Pasic J, Tan ZS, Wills CD, Rhoads R, Yager J.

Am J Psychiatry. 2016 May 1;173(5):543-6. doi: 10.1176/appi.ajp.2015.173501.

Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments

Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctôt KL.

Curr Alzheimer Res. 2016;13(10):1134-44. doi: 10.2174/1567205013666160502122933.

Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia

Umegaki H.

Drugs Aging. 2016 Jun;33(6):399-409. doi: 10.1007/s40266-016-0375-0.

The behavioral variant of frontotemporal dementia: An analysis of the literature and a case report

Birkhoff JM, Garberi C, Re L.

Int J Law Psychiatry. 2016 Jul-Aug;47:157-63. doi: 10.1016/j.ijlp.2016.04.001. Epub 2016 Apr 30.

NME8 rs2718058 polymorphism with Alzheimer's disease risk: a replication and meta-analysis

Liu SL, Wang XC, Tan MS, Wang HF, Zhang W, Wang ZX, Yu JT, Tan L.

Oncotarget. 2016 Jun 14;7(24):36014-36020. doi: 10.18632/oncotarget.9086.

R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation

Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R.

Br J Clin Pharmacol. 2016 Sep;82(3):784-92. doi: 10.1111/bcp.12997. Epub 2016 Jun 20.

Coronary artery disease in patients with dementia

Fowkes R, Byrne M, Sinclair H, Tang E, Kunadian V.

Coron Artery Dis. 2016 Sep;27(6):511-20. doi: 10.1097/MCA.0000000000000377.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias